MFGR1877S Uses, Dosage, Side Effects and more
MFGR1877S is under investigation in clinical trial NCT02401542 (Dose Escalation, Expansion Study of MFGR1877S (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma).
| Attribute | Details |
|---|---|
| Trade Name | MFGR1877S |
| Generic | Vofatamab |
| Vofatamab Other Names | MFGR1877S, Vofatamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
